Analyses on the Clinical Usefulness of Natural Killer Cell Activity in Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Choi, Sue In [1 ]
In, Kwnag Ho [1 ]
Kang, Kyung Ho [1 ]
Shim, Jae Jeong [1 ]
Shin, Chol [1 ]
Lee, Sang Yeub [1 ]
Kim, Je Hyeong [1 ]
Lee, Sung Yong [1 ]
Lee, Seung Heon [1 ]
Hur, Gyu Young [1 ]
Min, Kyung Hoon [1 ]
Lee, Eun Joo [1 ]
Jung, Won Jai [1 ]
机构：
[1] Korea Univ, Seoul, South Korea
来源：
CHEST | 2017年 / 152卷 / 04期
关键词：
D O I：
10.1016/j.chest.2017.08.693
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：663A / 663A
页数：1
相关论文
共 50 条
  • [1] Clinical usefulness of natural killer cell activity in patients with non-small cell lung cancer
    In, Kwang Ho
    Choi, Sue In
    Lee, Seung Hyeun
    Lee, Sang Yeub
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] Clinical usefulness of α-crystallin antibodies in non-small cell lung cancer patients
    Cherneva, Radostina
    Petrov, Danail
    Georgiev, Ognian
    Trifonova, Nedka
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2010, 10 (01) : 14 - 17
  • [3] The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
    Bruno, Antonino
    Focaccetti, Chiara
    Pagani, Arianna
    Imperatori, Andrea S.
    Spagnoletti, Marco
    Rotolo, Nicola
    Cantelmo, Anna Rita
    Franzi, Francesca
    Capella, Carlo
    Ferlazzo, Guido
    Mortara, Lorenzo
    Albini, Adriana
    Noonan, Douglas M.
    NEOPLASIA, 2013, 15 (02): : 133 - U191
  • [4] Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
    Russell, Eilis
    Conroy, Melissa J.
    Barr, Martin P.
    CELLS, 2022, 11 (04)
  • [5] The dynamics of natural killer cell activity as a prognostic factor in patients receiving curative surgery for non-small cell lung cancer
    Wen, Sara Witting Christensen
    Nederby, Line
    Hansen, Torben Frostrup
    Timm, Signe
    Borg, Morten
    Hilberg, Ole
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [6] EVALUATE THE NATURAL KILLER CELL ACTIVITY IN PATIENTS WITH ADVANCED STAGE NON SMALL CELL LUNG CANCER
    Do Quyet
    Ta Ba Thang
    Pham Thi Kim Nhung
    RESPIROLOGY, 2019, 24 : 57 - 57
  • [7] Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non-small cell lung cancer
    Choi, Myeong Geun
    Kim, Yeon Joo
    Lee, Jae Cheol
    Rho, Jin Kyung
    Choi, Chang-Min
    THORACIC CANCER, 2020, 11 (11) : 3337 - 3345
  • [8] Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study
    Choi, Sue In
    Lee, Seung Hyeun
    Park, Ji-Young
    Kim, Kyoung-Ah
    Lee, Eun Joo
    Lee, Sang Yeub
    In, Kwang Ho
    ONCOTARGETS AND THERAPY, 2019, 12 : 1661 - 1669
  • [9] Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors
    Wen, S. W. C.
    Hansen, T. S.
    Nederby, L.
    Andersen, R. F.
    Nyhus, C. H.
    Bertelsen, L.
    Sorensen, B. T.
    Hager, H.
    Hilberg, O.
    Jakobsen, A.
    Hansen, T. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S853 - S853
  • [10] Meta-analyses of clinical trials in patients with non-small cell lung cancer
    Kovac, V
    Smrdel, U
    NEOPLASMA, 2004, 51 (05) : 334 - 340
12345